Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states - A possible explanation for impaired collateral formation in cardiac tissue

被引:301
作者
Chou, E
Suzuma, I
Way, KJ
Opland, D
Clermont, AC
Naruse, K
Suzuma, K
Bowling, NL
Vlahos, CJ
Aiello, LP
King, GL
机构
[1] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA
[2] Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA
[5] Lilly Res Labs, Indianapolis, IN USA
关键词
growth substances; diabetes mellitus; myocardium; collateral circulation; insulin;
D O I
10.1161/hc0302.102143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Inadequate angiogenic response to ischemia in the myocardium of diabetic patients could result in poor collateral formation. Yet, excessive neovascularization in the retina causes proliferative diabetic retinopathy. Since vascular endothelial growth factor (VEGF) is the major angiogenic factor expressed in response to hypoxia, we have characterized expression of VEGF and its receptors in retina, renal glomeruli, aorta, and myocardium in insulin-resistant and diabetic states. Methods and Results-The expression of mRNA and protein for VEGF and its receptors, VEGF-R1 and VEGF-R2, in the myocardium was decreased significantly by 40% to 70% in both diabetic and insulin-resistant nondiabetic rats. Twofold reductions in VEGF and VEGF-R2 were observed in ventricles from diabetic patients compared with nondiabetic donors. In contrast, expression of VEGF and its receptors were increased 2-fold in retina and glomeruli from diabetic or insulin-resistant rats. Insulin treatment of diabetic rats normalized changes in both cardiac and microvascular tissues. Insulin increased VEGF mRNA expression in cultured rat neonatal cardiac myocytes. Conclusions-The results documented for the first time that differential regulation of VEGF and its receptors exist between microvascular and cardiac tissues, which can be regulated by insulin. These results provide a potential explanation for concomitant capillary leakage and neovascularization in the retina and inadequate collateral formation in the myocardium of insulin-resistant and diabetic patients.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 31 条
  • [1] Effect of diabetes mellitus on formation of coronary collateral vessels
    Abaci, A
    Oguzhan, A
    Kahraman, S
    Eryol, NK
    Ünal, S
    Arinç, H
    Ergin, A
    [J]. CIRCULATION, 1999, 99 (17) : 2239 - 2242
  • [2] INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY
    ADAMIS, AP
    MILLER, JW
    BERNAL, MT
    DAMICO, DJ
    FOLKMAN, J
    YEO, TK
    YEO, KT
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) : 445 - 450
  • [3] Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
    Aiello, LP
    Bursell, SE
    Clermont, A
    Duh, E
    Ishii, H
    Takagi, C
    Mori, F
    Ciulla, TA
    Ways, K
    Jirousek, M
    Smith, LEH
    King, GL
    [J]. DIABETES, 1997, 46 (09) : 1473 - 1480
  • [4] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [5] Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent
    Bernatchez, PN
    Soker, S
    Sirois, MG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 31047 - 31054
  • [6] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [7] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
    Cooper, ME
    Vranes, D
    Youssef, S
    Stacker, SA
    Cox, AJ
    Rizkalla, B
    Casley, DJ
    Bach, LA
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES, 1999, 48 (11) : 2229 - 2239
  • [8] De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
  • [9] The biology of vascular endothelial growth factor
    Ferrara, N
    DavisSmyth, T
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 4 - 25
  • [10] Insulin sensitivity in subjects with type 2 diabetes - Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study
    Haffner, SM
    D'Agostino, R
    Mykkanen, L
    Tracy, R
    Howard, B
    Rewers, M
    Selby, J
    Savage, PJ
    Saad, MF
    [J]. DIABETES CARE, 1999, 22 (04) : 562 - 568